Replies to post #6226 on Arbutus Biopharma Corporation (ABUS)

[mick]

thank you good repore' $ABUS

[mick]

$ABUS 01-16-2021 STILL WAITING FOR PATENT INFRINGE MENT ROYALTIES
FROM $PFE $BNTX $MRNA PRIVATE ONE Genevant OR SETTLEMENT
https://investorshub.advfn.com/Arbutus-Biopharma-Corporation-ABUS-17838/
HAS GREAT POTENTIAL BECAUSE OF PATENT INFRINGEMENT BY $PFE $BNTX $MRNA
PRIVATE ONE Genevant
https://investorshub.advfn.com/Pfizer-Inc-PFE-995/
https://investorshub.advfn.com/Moderna-Inc-MRNA-36438/
https://investorshub.advfn.com/BioNTech-SE-ADR-BNTX-37289/
With Genevant using ABUS LNP patented technology in a deal with Providence Theraputics for a Canadian Covid-19 vaccine going into Ph. 1 trials, wonder if we get a PR this week. Canadian Government helping fund the effort is a nice bonus to ensure the testing will progress and won't stall due to lack of funding.

https://www.providencetherapeutics.com/providence-therapeutics-confirms-government-of-canada-will-support-its-phase-1-clinical-trials-for-a-covid-19-vaccine
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160500260&txt2find=Genevant